Rebecca Katzy
- Name
- R.E. Katzy MSc
- ORCID iD
- 0000-0002-4188-5795
- Katzy R.E., Neer R.H.P. van, Guimaraes Da Lomba Ferraz M.J., Nicolai K., Passioura T., Suga H., Jongkees S.A.K. & Artola Perez de Azanza M.E. (2025), Development of selective nanomolar cyclic peptide ligands as GBA1 enzyme stabilisers, RSC Chemical Biology 6(4): 563-570.
- Kok K., Kuo C.L., Katzy R.E., Lelieveld L.T., Wu L., Roig-Zamboni V., Marel G.A. van der, Codee J.D.C., Sulzenbacher G., Davies G.J., Overkleeft H.S., Aerts J.M.F.G. & Artola Perez de Azanza M.E. (2022), 1,6-epi-Cyclophellitol cyclosulfamidate is a bona fide lysosomal α-glucosidase stabilizer for the treatment of Pompe disease, Journal of the American Chemical Society 144(32): 14819-14827.
- Katzy R.E., Guimaraes Da Lomba Ferraz M.J., Hazeu M.D., Overkleeft H.S. & Aerts J.M.F.G. (2022), In situ glucosylceramide synthesis and its pharmacological inhibition analysed in cells by 13C5-sphingosine precursor feeding and mass spectrometry, FEBS Letters 596(18): 2400-2408.
- Kytidou K., Beekwilder J., Artola M., Meel E. van, Wilbers R.H.P., Moolenaar G.F., Goosen N., Ferraz M.J., Katzy R., Voskamp P., Florea B.I., Hokke C.H., Overkleeft H.S., Schots A., Bosch D., Pannu N. & Aerts J.M.F.G. (2018), Nicotiana benthamiana α-galactosidase A1.1 can functionally complement human α-galactosidase A deficiency associated with Fabry disease, Journal of Biological Chemistry 293(26): 10042-10058.